Exam Details
Subject | pathology | |
Paper | paper 3 | |
Exam / Course | ||
Department | ||
Organization | National Board of Examinations | |
Position | ||
Exam Date | June, 2017 | |
City, State | delhi, |
Question Paper
FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
JUNE 2017
POSSESSION USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.
PATHOLOGY
PAPER III
PATH/J/17/32/III
Time 3 hours
Max. Marks 100
Important instructions:
• Attempt all questions in order.
• Each question carries 10 marks.
• Read the question carefully and answer to the point neatly and legibly.
• Do not leave any blank pages between two answers.
• Indicate the question number correctly for the answer in the margin space.
• Answer all the parts of a single question together.
• Start the answer to a question on a fresh page or leave adequate space between two answers.
• Draw table/diagrams/flowcharts wherever appropriate.
Write short notes on:
1. Groove pancreatitis.
Familial glomerulopathies.
5+5
2. Premalignant skin lesions.
Serous tubal intraepithelial carcinoma (STIC) and secretory cell
overgrowth (SCOUTs) lesions.
5+5
3. PEComas.
Cortical dysplasia and its type.
5+5
4. Molecular classification of breast cancer and its role in patient
management.
Myxoid soft tissue tumours.
5+5
5. Extra-intestinal manifestation and lesions in association with
inflammatory bowel disease (IBD).
Pancreatic intra-epithelial neoplasia (PanIN) and biliary intra-epithelial
neoplasia (BilIN).
5+5
6. Histopathological changes in placenta in various infections and in
pregnancy induced hypertension (PIH).
H3 K27M midline diffuse glioma.
5+5
7. Tumour like lesions of bone.
Chromoendoscopy directed lesional biopsies advantages and
disadvantages.
5+5
8. Newly introduced various immunohistochemistry markers in diagnostic
domain of liver lesions with special reference to dysplastic vs malignant
lesions.
Micro satellite instability and panel of IHC to detect MSI low Vs
MSI high lesions.
5+5
9. MiT family translocation renal cell carcinomas.
Role of PDL-1 as biomarker testing for non small cell lung cancers.
5+5
10. Compare and contrast between dermatomyositis and IBM inclusion
body myositis.
Recent advances and prognosis of idiopathic membranous nephropathy.
5+5
JUNE 2017
POSSESSION USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.
PATHOLOGY
PAPER III
PATH/J/17/32/III
Time 3 hours
Max. Marks 100
Important instructions:
• Attempt all questions in order.
• Each question carries 10 marks.
• Read the question carefully and answer to the point neatly and legibly.
• Do not leave any blank pages between two answers.
• Indicate the question number correctly for the answer in the margin space.
• Answer all the parts of a single question together.
• Start the answer to a question on a fresh page or leave adequate space between two answers.
• Draw table/diagrams/flowcharts wherever appropriate.
Write short notes on:
1. Groove pancreatitis.
Familial glomerulopathies.
5+5
2. Premalignant skin lesions.
Serous tubal intraepithelial carcinoma (STIC) and secretory cell
overgrowth (SCOUTs) lesions.
5+5
3. PEComas.
Cortical dysplasia and its type.
5+5
4. Molecular classification of breast cancer and its role in patient
management.
Myxoid soft tissue tumours.
5+5
5. Extra-intestinal manifestation and lesions in association with
inflammatory bowel disease (IBD).
Pancreatic intra-epithelial neoplasia (PanIN) and biliary intra-epithelial
neoplasia (BilIN).
5+5
6. Histopathological changes in placenta in various infections and in
pregnancy induced hypertension (PIH).
H3 K27M midline diffuse glioma.
5+5
7. Tumour like lesions of bone.
Chromoendoscopy directed lesional biopsies advantages and
disadvantages.
5+5
8. Newly introduced various immunohistochemistry markers in diagnostic
domain of liver lesions with special reference to dysplastic vs malignant
lesions.
Micro satellite instability and panel of IHC to detect MSI low Vs
MSI high lesions.
5+5
9. MiT family translocation renal cell carcinomas.
Role of PDL-1 as biomarker testing for non small cell lung cancers.
5+5
10. Compare and contrast between dermatomyositis and IBM inclusion
body myositis.
Recent advances and prognosis of idiopathic membranous nephropathy.
5+5
Other Question Papers
Subjects
- anaesthesia
- anaesthesiology
- anatomy
- biochemistry
- cardio thoracic surgery
- cardiologypaper 1.
- cardiologypaper 2.
- cardiologypaper 3.
- dermatology, venereology & leprosy
- emergency medicine
- endocirnology
- ent
- family medicine
- field epidemo
- forensic medicie
- gastroenterology
- general medicine
- general surgery
- genito urinary surgery
- health admin including hospital administration
- hematology
- immuno-hemato & blood transfusion
- immuno-hematology & transfusion medicine
- medical genetics
- medical oncology
- microbiology
- neonatology
- nephrology
- neuro surgery
- neurology
- nuclear medicine
- obstetrics & gynaecology
- ophthalmology
- orthopedics
- otorhinolaryngology (ent)
- pathology
- pediatric surgery
- pediatrics
- pharma
- physical medicine & rehabilitation
- physiology
- plastic surgery
- psychiarty
- pvs
- radiodiagnosis
- radiotherapy
- rdg
- respiratory disease
- rheumatology
- rural surgery
- social & preventive medicine
- surgical gastroenterology
- surgical oncology
- thoracic surgery
- tuberculosis & respiratory diseases/pulmonary medicine